For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells in a ...

Lead program advancing to IND filing in H1 2025 for the treatment of X-linked chronic granulomatous disease (X-CGD) will be first in vivo HSC-directed therapy tested in humans Preclinical data to be ...

Magnetic nanoparticles engineered T cells inside living mice and guided them into solid tumors, achieving over 90% tumor ...

Funded by the UB Provost, the new Center for Cell, Gene and Tissue Engineering (CGTE) will be led by SUNY Distinguished Professor Stelios Andreadis. “I am very happy to announce the launch of the Cell ...

Luxury skincare is one of the largest markets for Asian consumers, particularly women, and recently Hong Kong has seen one of its own homegrown brands disrupting the industry. Founded by two young ...

New research may offer hope for endangered species Findings offer potential for regenerative medicine field Earlier study used different method for 'bipaternal' mice Jan 28 (Reuters) - Scientists in ...

Key market opportunities in the global competent cells market include rising demands in genetic engineering and synthetic ...

UBC research associate Dr. Ross Jones in the lab where they are working to develop cell-based therapies from stem cells. Credit: Phillip Chin. For the first time, researchers at the University of ...